Outcomes of Pediatric Osteogenesis Imperfecta Patients Requiring Port‐a‐Cath Placement for Long‐Term Vascular Access

Intravenous (iv) bisphosphonates are widely used to treat the skeletal manifestations of osteogenesis imperfecta (OI). Obtaining peripheral iv access in pediatric patients with OI is often difficult and traumatic. Although this may be mitigated with surgically placed iv ports (port‐a‐caths), surgeon...

Descripción completa

Detalles Bibliográficos
Autores principales: White, Andrew C, Byrd, Jay J, Schissel, Makayla, Strudthoff, Elizabeth, Wallace, Maegen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339085/
https://www.ncbi.nlm.nih.gov/pubmed/37457882
http://dx.doi.org/10.1002/jbm4.10752

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339085/
https://www.ncbi.nlm.nih.gov/pubmed/37457882
http://dx.doi.org/10.1002/jbm4.10752

Ejemplares similares